All news

8 results out of 25
12 October 2015
The PIA, via Bpifrance, invests in AFM-Téléthon biotherapies plant
AFM-Téléthon and Fund SPI, managed by Bpifrance within the framework of the PIA, join to create the biggest European development and production plant for gene and cell therapies to provide the sick with curative therapeutic treatments mass-produced from 2019.
25 September 2015
The PIA, via Bpifrance, supports the development of Vulog and iAdvize
The Program of investments for the future (PIA) supports via Bpifrance the development of two digital service companies, Vulog and iAdvize. To enable them to go on growing, in particular internationally, the PIA participates in their fundraisings of respectively €8.4mn and €14mn.
09 January 2015
Life sciences: Bpifrance supports Sight Again and Cellectis
Bpifrance, as an operator of the PIA, allocates €18.5mn to Sight Againt collaborative project developed by GenSight Biologics, Pixium Vision and Voir et Entendre foundation, whereas Cellectis, the main shareholder of which is Bpifrance, announces its coming IPO on the New York Stock Exchange.
18 February 2015
Bpifrance supports three biotech projects within the framework of the PIA
Bpifrance supports, within the framework of the Program of investments for the future (PIA), three projects in the field of biotechnology: Hecam (cancer research), AAVLife (gene therapy) and Algolife (nutrition & health).
18 February 2015
The PIA and Bpifrance participate in Sigfox €100mn fundraising
Fonds Ambition Numérique of the PIA, subscribed by Caisse des Dépôts and managed by Bpifrance for the State, participates in Sigfox €100mn fundraising. Bpifrance also plays a part with its Large Venture fund, beside telecommunication operators, manufacturers and financial investors.
04 February 2015
Cap Innov'Est: €36mn for the innovative companies in Alsace, Burgundy and Franche-Comté
The first projects chosen within the framework of Cap Innov'Est new interregional seed fund were presented on 4 February 4th in the presence of the partners, the financers, the managers and the leaders of BioNext, Inoviem Scientific and Medical DTA companies, the first beneficiaries of this new financial tool.
26 February 2015
€104mn more for the first five SATTs
On 26 February, Emmanuel Macron, Geneviève Fioraso and Louis Schweitzer announced further financing, for a €104mn total amount, for the first five Companies of acceleration of technology transfer (SATT) created in 2012, via the maturation fund co-managed by ANR and Caisse des Dépôts for the behalf of the State.
01 April 2014
A company and 2 innovative projects supported by Bpifrance within the framework of the PIA
Bpifrance is supporting a company and two innovative projects within the framework of the Program of investments for the future (PIA): Augure, within the framework of its €15mn fund raising, Vue-Flex and S2P via a financing of €5mn and €3mn respectively.
Haut de page